NO20014231L - Innkapsling av bioaktive komplekser i liposomer - Google Patents

Innkapsling av bioaktive komplekser i liposomer

Info

Publication number
NO20014231L
NO20014231L NO20014231A NO20014231A NO20014231L NO 20014231 L NO20014231 L NO 20014231L NO 20014231 A NO20014231 A NO 20014231A NO 20014231 A NO20014231 A NO 20014231A NO 20014231 L NO20014231 L NO 20014231L
Authority
NO
Norway
Prior art keywords
liposomes
encapsulation
bioactive agents
bioactive complexes
bioactive
Prior art date
Application number
NO20014231A
Other languages
English (en)
Other versions
NO20014231D0 (no
Inventor
Paul Meers
Tong Shangguan
Donna Cabral-Lilly
Andrew Janoff
Patrick Ahl
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of NO20014231D0 publication Critical patent/NO20014231D0/no
Publication of NO20014231L publication Critical patent/NO20014231L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

Denne oppfinnelsen tilveiebringer en fremgangsmåte for å fremstille liposominnkasplede bioaktive midler slik som nukleinsyre, som omfatter kompleksdannelse av de bioaktive midlene i reverse miceller forut for danning av liposomer, så vel som fremgangsmåter for å anvende liposomene som er dannet og formuleringer for å avlevere nukleinsyrer til celler.
NO20014231A 1999-03-02 2001-08-31 Innkapsling av bioaktive komplekser i liposomer NO20014231L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12236599P 1999-03-02 1999-03-02
PCT/US2000/005395 WO2000051565A1 (en) 1999-03-02 2000-03-01 Encapsulation of bioactive complexes in liposomes

Publications (2)

Publication Number Publication Date
NO20014231D0 NO20014231D0 (no) 2001-08-31
NO20014231L true NO20014231L (no) 2001-10-03

Family

ID=22402271

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014231A NO20014231L (no) 1999-03-02 2001-08-31 Innkapsling av bioaktive komplekser i liposomer

Country Status (20)

Country Link
US (2) US7491409B1 (no)
EP (1) EP1156783B1 (no)
JP (1) JP2002538096A (no)
KR (1) KR20010112301A (no)
CN (1) CN1349402A (no)
AT (1) ATE376413T1 (no)
AU (1) AU3715900A (no)
BR (1) BR0008711A (no)
CA (1) CA2362485A1 (no)
CZ (1) CZ20013103A3 (no)
DE (1) DE60036861T2 (no)
EA (1) EA200100856A1 (no)
ES (1) ES2295018T3 (no)
HU (1) HUP0200114A2 (no)
IL (1) IL145117A0 (no)
NO (1) NO20014231L (no)
NZ (1) NZ513829A (no)
PL (1) PL351487A1 (no)
WO (1) WO2000051565A1 (no)
ZA (1) ZA200107205B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200100856A1 (ru) * 1999-03-02 2002-02-28 ДЗЕ ЛИПОСОМ КОМПАНИ, Инк. Способ инкапсулирования биологически активных комплексов в липосомы
KR100822684B1 (ko) * 2000-10-04 2008-04-17 교와 핫꼬 고교 가부시끼가이샤 지질막에 의한 미립자의 피복방법
WO2002080981A2 (en) * 2001-04-04 2002-10-17 Nordic Vaccine Technology A/S Polynucleotide binding complexes comprising sterols and saponins
US7713942B2 (en) 2001-04-04 2010-05-11 Nordic Vaccine Technology A/S Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
JP4370451B2 (ja) * 2001-09-28 2009-11-25 大塚製薬株式会社 医薬組成物
EP1474107A4 (en) * 2002-01-09 2010-01-20 Transave Inc EFFECTIVE ENCAPSULATION IN LIPOSOMES IN SOFT CONDITIONS
AU2003205049B2 (en) * 2002-01-09 2009-05-28 Transave, Inc. Efficient nucleic acid encapsulation into medium sized liposomes
CA2478479A1 (en) 2002-03-07 2003-09-18 University Of Delaware Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phagebeta protein, or hydroxyurea
US20030235916A1 (en) * 2002-06-14 2003-12-25 Monahan Sean D. Novel methods for the delivery of polynucleotides to cells
US20080171090A1 (en) * 2005-01-28 2008-07-17 Nobuhiro Yagi Method Of Producing Coated Fine Particles
US20090305409A1 (en) * 2005-03-24 2009-12-10 National University Corporation Hokkaido University Liposome Capable of Effective Delivery of Given Substance Into Nucleus
DE602006021587D1 (de) * 2005-09-30 2011-06-09 Univ Hokkaido Nat Univ Corp Vektor zur zuführung einer zielsubstanz in den zellkern oder die zelle
EP2160607B1 (en) * 2007-05-31 2011-09-07 Sanofi Assay methods for identifying agents that modify the activity of nape-pld or abh4
US8784659B2 (en) 2007-08-08 2014-07-22 General Electric Company Method for controlling microbial biofilm in aqueous systems
JP5475753B2 (ja) 2008-04-15 2014-04-16 プロチバ バイオセラピューティクス インコーポレイティッド 核酸送達用の脂質製剤
CA3039251C (en) 2008-11-10 2024-01-09 Arbutus Biopharma Corporation Novel lipids and compositions for the delivery of therapeutics
JP5766188B2 (ja) 2009-07-01 2015-08-19 プロチバ バイオセラピューティクス インコーポレイティッド 固形腫瘍に治療剤を送達するための脂質製剤
US20110177147A1 (en) * 2010-01-21 2011-07-21 General Electric Company Stable biocidal delivery systems
KR101102834B1 (ko) * 2010-02-24 2012-01-05 충남대학교산학협력단 신규한 리포좀 제조 방법 및 장치
KR101198715B1 (ko) * 2010-05-14 2012-11-13 한국생명공학연구원 핵산 및 친수성 음이온 화합물의 고효율 포획을 위한 비대칭 리포솜 및 이의 제조방법
WO2012000104A1 (en) 2010-06-30 2012-01-05 Protiva Biotherapeutics, Inc. Non-liposomal systems for nucleic acid delivery
FR2964569B1 (fr) * 2010-09-10 2012-10-19 Ct De Cooperation Internationale En Rech Agronomique Pour Le Dev Cirad Nouveaux liposomes de vaccination genique
EP2683410A2 (en) * 2011-03-08 2014-01-15 Access Pharmaceuticals, Inc. Targeted nanocarrier systems for delivery of actives across biological membranes
US9758395B2 (en) 2011-04-28 2017-09-12 Aquero Company, Llc Lysine-based polymer coagulants for use in clarification of process waters
WO2014186336A1 (en) 2013-05-17 2014-11-20 3M Innovative Properties Company Release of biologically active agents from polymeric composite particles
CN105228820B (zh) 2013-05-17 2017-08-29 3M创新有限公司 反应混合物、多孔粒子以及制备方法
CA3106893A1 (en) * 2018-07-21 2020-01-30 University Of Tennessee Research Foundation Neutral liposomes containing biologically active agents
KR20210143906A (ko) * 2019-03-29 2021-11-29 글라이코민 인코포레이티드 리포솜 제제, 및 이의 사용 및 제조 방법
EP3739321B1 (de) * 2019-05-17 2023-03-08 Xtal Concepts GmbH Qualifizierungsverfahren für kryoelektronenmikroskopie-proben sowie dazugehöriger probenhalter
WO2022045009A1 (ja) * 2020-08-24 2022-03-03 国立大学法人山口大学 流体を追跡するための組成物及び流体の追跡方法
EP4314327A1 (en) 2021-03-22 2024-02-07 Illumina Cambridge Limited Methods for improving nucleic acid cluster clonality
CN113785975B (zh) * 2021-09-09 2023-08-29 天津医科大学 精胺、亚精胺脂质体在抗氧化、抗衰老中的应用
DE102022134188B3 (de) 2022-12-20 2024-03-28 Universität Augsburg - Körperschaft des öffentlichen Rechts Verfahren zur in-situ Erfassung von Änderungen eines Lipidsystems bei dessen Lagerung bei einer Lagertemperatur unterhalb von -60 °C

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723147A (en) 1987-02-23 1998-03-03 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
US5286634A (en) * 1989-09-28 1994-02-15 Stadler Joan K Synergistic method for host cell transformation
ATE227979T1 (de) * 1993-04-22 2002-12-15 Skyepharma Inc Multivesikuläre liposomen mit verkapseltem cyclodextrin und pharmakologisch wirksamen verbindungen sowie verfahren zu deren verwendung
US5795587A (en) * 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
JP2001510457A (ja) * 1996-11-12 2001-07-31 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア インビボ送達に有効な、脂質―核酸複合体の安定な製剤の調製
EA200100856A1 (ru) * 1999-03-02 2002-02-28 ДЗЕ ЛИПОСОМ КОМПАНИ, Инк. Способ инкапсулирования биологически активных комплексов в липосомы

Also Published As

Publication number Publication date
HUP0200114A2 (hu) 2002-05-29
IL145117A0 (en) 2002-06-30
NO20014231D0 (no) 2001-08-31
BR0008711A (pt) 2002-10-01
CN1349402A (zh) 2002-05-15
US20090068256A1 (en) 2009-03-12
EA200100856A1 (ru) 2002-02-28
ZA200107205B (en) 2002-12-02
CA2362485A1 (en) 2000-09-08
DE60036861T2 (de) 2008-07-24
JP2002538096A (ja) 2002-11-12
ES2295018T3 (es) 2008-04-16
EP1156783B1 (en) 2007-10-24
US7491409B1 (en) 2009-02-17
DE60036861D1 (de) 2007-12-06
ATE376413T1 (de) 2007-11-15
AU3715900A (en) 2000-09-21
WO2000051565A1 (en) 2000-09-08
EP1156783A1 (en) 2001-11-28
EP1156783A4 (en) 2003-05-21
WO2000051565A9 (en) 2002-02-14
NZ513829A (en) 2001-09-28
PL351487A1 (en) 2003-04-22
KR20010112301A (ko) 2001-12-20
CZ20013103A3 (cs) 2002-01-16

Similar Documents

Publication Publication Date Title
NO20014231L (no) Innkapsling av bioaktive komplekser i liposomer
WO2002038105A3 (en) Novel polyamine analog-amino acid conjugates useful as anticancer agents
WO1999018933A3 (en) Methods for encapsulating nucleic acids in lipid bilayers
IL140710A0 (en) Pulmonary delivery of active agents
WO2002074238A3 (en) Water soluble and palatable complexes
WO2000066175A3 (en) Conjugates as therapies for cancer and prostate diseases
WO2001032596A8 (en) Phenoxy carboxylic acid compounds and compositions for delivering active agents
WO2001079459A3 (en) Polypeptides having haloperoxidase activity
IL142864A0 (en) Compositions and methods for producing vascular occlusion
WO2002000194A3 (en) Polymeric micelle compositions
WO2002002077A3 (en) Liposomal antineoplastic drugs and uses thereof
IL140930A0 (en) Compounds and compositions for delivering active agents
EP0993831A3 (en) Compounds and compositions for delivering active agents
CA2468916A1 (en) A stable oxaliplatin solution formulation
WO2003030829A3 (en) Liposome-encapsulated insulin formulations
IL161812A (en) STABLE FORMULATION OF Apo-2 LIGAND AND A METHOD FOR MANUFACTURING IT
WO2001005355A3 (en) Formulations for il-11
CA2407747A1 (en) Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts
WO2002015959A3 (en) Compounds and compositions for delivering active agents
AU7134898A (en) Biodegradable microparticles for the sustained delivery of therapeutic drugs
MXPA02012068A (es) Formulaciones liposomales inhibidoras de la timidilato de benzoqunazolina sintasa.
MXPA02011389A (es) Forma de administracion farmaceutica para peptidos, procedimiento para su preparacion y aplicacion.
BG106008A (en) Novel lhrh antagonists with improved solubility characteristics
GB2316945B (en) Preparation of 3-amino-1-hydroxypropane-1,1-diphosphonic acid
HUP0100350A2 (hu) A prosztatarák kezelésére alkalmazható konjugátumok, azokat hatóanyagként tartalmazó gyógyászati készítmények, elárás ezek előállítására, valamint alkalmazásuk

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application